About Eli Lilly
Industry:
Pharmaceuticals
Founded:
1876
Founders:
Eli Lilly
Status:
Public (NYSE: LLY)
Funding & Growth
Total Raised:
N/A
Valuation:
$700B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Exceptional stock performance and growth
- • Strong diabetes and obesity pipeline (Mounjaro)
- • Heavy R&D investment
- • Good work-life balance
- • Excellent benefits
✗ Cons
- • Indianapolis location
- • Large company bureaucracy
- • Midwest location may not appeal to all
- • Competitive internally